Fatoumatta Darboe

1.3k total citations
11 papers, 294 citations indexed

About

Fatoumatta Darboe is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, Fatoumatta Darboe has authored 11 papers receiving a total of 294 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 7 papers in Epidemiology and 5 papers in Immunology. Recurrent topics in Fatoumatta Darboe's work include Tuberculosis Research and Epidemiology (7 papers), Mycobacterium research and diagnosis (6 papers) and Immunodeficiency and Autoimmune Disorders (4 papers). Fatoumatta Darboe is often cited by papers focused on Tuberculosis Research and Epidemiology (7 papers), Mycobacterium research and diagnosis (6 papers) and Immunodeficiency and Autoimmune Disorders (4 papers). Fatoumatta Darboe collaborates with scholars based in South Africa, United States and Gambia. Fatoumatta Darboe's co-authors include Adam Penn‐Nicholson, Thomas J. Scriba, Willem A. Hanekom, Francesco Vallania, Stephanus T. Malherbe, Qianting Yang, Cesar J. Lopez Angel, Xinchun Chen, Jill Winter and Yueh‐hsiu Chien and has published in prestigious journals such as Nature, PLoS ONE and Frontiers in Immunology.

In The Last Decade

Fatoumatta Darboe

11 papers receiving 290 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fatoumatta Darboe South Africa 9 169 134 123 57 46 11 294
Youchao Dai China 8 126 0.7× 136 1.0× 103 0.8× 98 1.7× 35 0.8× 13 297
Krystle K. Q. Yu United States 7 171 1.0× 164 1.2× 99 0.8× 36 0.6× 26 0.6× 9 242
Andrea Schaeffer United States 6 42 0.2× 75 0.6× 76 0.6× 54 0.9× 17 0.4× 11 225
One Dintwe South Africa 7 129 0.8× 154 1.1× 83 0.7× 48 0.8× 15 0.3× 10 224
Gaspar A. Pacheco Chile 8 85 0.5× 86 0.6× 120 1.0× 35 0.6× 20 0.4× 11 238
Helen Ferreira Brazil 12 219 1.3× 78 0.6× 159 1.3× 38 0.7× 85 1.8× 22 315
Kaori L. Fonseca Portugal 5 180 1.1× 128 1.0× 129 1.0× 72 1.3× 42 0.9× 6 282
Magali Matsumiya United Kingdom 10 162 1.0× 125 0.9× 96 0.8× 43 0.8× 28 0.6× 10 228
Jackelyn Crabtree United States 9 104 0.6× 82 0.6× 188 1.5× 86 1.5× 15 0.3× 9 324
Michelle Rohlfing United States 5 46 0.3× 192 1.4× 100 0.8× 61 1.1× 15 0.3× 13 335

Countries citing papers authored by Fatoumatta Darboe

Since Specialization
Citations

This map shows the geographic impact of Fatoumatta Darboe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fatoumatta Darboe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fatoumatta Darboe more than expected).

Fields of papers citing papers by Fatoumatta Darboe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fatoumatta Darboe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fatoumatta Darboe. The network helps show where Fatoumatta Darboe may publish in the future.

Co-authorship network of co-authors of Fatoumatta Darboe

This figure shows the co-authorship network connecting the top 25 collaborators of Fatoumatta Darboe. A scholar is included among the top collaborators of Fatoumatta Darboe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fatoumatta Darboe. Fatoumatta Darboe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Darboe, Fatoumatta, et al.. (2024). Unmasking the hidden impact of viruses on tuberculosis risk. Trends in Immunology. 45(9). 649–661. 1 indexed citations
2.
Baguma, Richard, Stanley Kimbung Mbandi, Mzwandile Erasmus, et al.. (2021). Inflammatory Determinants of Differential Tuberculosis Risk in Pre-Adolescent Children and Young Adults. Frontiers in Immunology. 12. 639965–639965. 11 indexed citations
3.
Mendelsohn, Simon C., Humphrey Mulenga, Stanley Kimbung Mbandi, et al.. (2021). Host blood transcriptomic biomarkers of tuberculosis disease in people living with HIV: a systematic review protocol. BMJ Open. 11(8). e048623–e048623. 3 indexed citations
4.
Adu-Gyamfi, Clement Gascua, Tracy Snyman, Kennedy Otwombe, et al.. (2020). Diagnostic accuracy of plasma kynurenine/tryptophan ratio, measured by enzyme-linked immunosorbent assay, for pulmonary tuberculosis. International Journal of Infectious Diseases. 99. 441–448. 14 indexed citations
5.
Darboe, Fatoumatta, Amadou Barry, Awa Gindeh, et al.. (2020). Monitoring Anti-tuberculosis Treatment Response Using Analysis of Whole Blood Mycobacterium tuberculosis Specific T Cell Activation and Functional Markers. Frontiers in Immunology. 11. 572620–572620. 8 indexed citations
6.
Llibre, Alba, Nicole Bilek, Vincent Bondet, et al.. (2019). Plasma Type I IFN Protein Concentrations in Human Tuberculosis. Frontiers in Cellular and Infection Microbiology. 9. 296–296. 11 indexed citations
7.
Chowdhury, Roshni Roy, Francesco Vallania, Qianting Yang, et al.. (2018). A multi-cohort study of the immune factors associated with M. tuberculosis infection outcomes. Nature. 560(7720). 644–648. 156 indexed citations
8.
Darboe, Fatoumatta, John Reynolds, Safayet Hossin, et al.. (2017). Minimal Sex-Differential Modulation of Reactivity to Pathogens and Toll-Like Receptor Ligands following Infant Bacillus Calmette–Guérin Russia Vaccination. Frontiers in Immunology. 8. 1092–1092. 10 indexed citations
9.
Parihar, Suraj P., Mumin Ozturk, Mohlopheni J. Marakalala, et al.. (2017). Protein kinase C-delta (PKCδ), a marker of inflammation and tuberculosis disease progression in humans, is important for optimal macrophage killing effector functions and survival in mice. Mucosal Immunology. 11(2). 496–511. 35 indexed citations
10.
Portevin, Damien, Klaus Reither, Francis Mhimbira, et al.. (2017). Mixed Th1 and Th2 Mycobacterium tuberculosis-specific CD4 T cell responses in patients with active pulmonary tuberculosis from Tanzania. PLoS neglected tropical diseases. 11(7). e0005817–e0005817. 32 indexed citations
11.
Afolabi, Muhammed O., Jorjoh Ndure, Fatoumatta Darboe, et al.. (2013). A Phase I Randomized Clinical Trial of Candidate Human Immunodeficiency Virus type 1 Vaccine MVA.HIVA Administered to Gambian Infants. PLoS ONE. 8(10). e78289–e78289. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Youchao Dai Breakdown of academic impact, for papers by Krystle K. Q. Yu Breakdown of academic impact, for papers by Andrea Schaeffer Breakdown of academic impact, for papers by One Dintwe Breakdown of academic impact, for papers by Gaspar A. Pacheco Breakdown of academic impact, for papers by Helen Ferreira Breakdown of academic impact, for papers by Kaori L. Fonseca Breakdown of academic impact, for papers by Magali Matsumiya Breakdown of academic impact, for papers by Jackelyn Crabtree Breakdown of academic impact, for papers by Michelle Rohlfing
Rankless by CCL
2026